Andrew C. Karaplis, et.al., Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice., Endocrinology, 2012, 153

http://rdf.ncbi.nlm.nih.gov/pubmed/23038738

Andrew C. Karaplis, et.al., Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice., Endocrinology, 2012, 153

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal osteoid morphology_Tg(APOE-FGF23*R176Q)#Ack/0
  http://metadb.riken.jp/0010924IC57BL6JCBATgAPOEFGF23R176QAck0TgAPOEFGF23R176QAck
• enthesitis_Phex<Hyp>/?
  http://metadb.riken.jp/0013942IC57BL6JPhexHypPhexHyp
• enthesitis_Tg(APOE-FGF23*R176Q)#Ack/0
  http://metadb.riken.jp/0013942IC57BL6JCBATgAPOEFGF23R176QAck0TgAPOEFGF23R176QAck
• abnormal fibrocartilage morphology_Phex<Hyp>/?
  http://metadb.riken.jp/0006431IC57BL6JPhexHypPhexHyp
• abnormal fibrocartilage morphology_Tg(APOE-FGF23*R176Q)#Ack/0
  http://metadb.riken.jp/0006431IC57BL6JCBATgAPOEFGF23R176QAck0TgAPOEFGF23R176QAck
• abnormal enthesis morphology_Tg(APOE-FGF23*R176Q)#Ack/0
  http://metadb.riken.jp/0013941IC57BL6JCBATgAPOEFGF23R176QAck0TgAPOEFGF23R176QAck